Endostatin in disease modulation: From cancer to beyond

Area of Science:

• Biomedical research
• Molecular biology
• Pathology

Background:

• Angiogenesis is crucial in diseases, making anti-angiogenic therapies a key focus.
• Endogenous angiogenesis inhibitors, like endostatin, offer therapeutic potential.
• Recombinant human endostatin has been used clinically in China for nearly 20 years.

Purpose of the Study:

• To review the multifaceted applications of endostatin.
• To examine endostatin's role in ocular diseases, inflammation, reproductive disorders, and tumor angiogenesis.
• To explore emerging roles of endostatin beyond angiogenesis, including in atherosclerosis and fibroproliferative conditions.

Main Methods:

• Literature review
• Analysis of existing research on endostatin
• Synthesis of data on endostatin's therapeutic applications

Main Results:

• Endostatin demonstrates anti-angiogenic, anti-atherosclerotic, and anti-fibrotic properties.
• Its therapeutic potential extends to various conditions including cancer, ocular diseases, and inflammation.
• Broader applications beyond angiogenesis are emerging, particularly in atherosclerosis and fibroproliferative diseases.

Conclusions:

• Endostatin possesses a wide therapeutic scope beyond its anti-cancer effects.
• Further exploration of endostatin's potential in diverse pathological conditions is warranted.
• Endostatin represents a promising therapeutic agent for angiogenesis-dependent and other diseases.